Table 1 Demographic, comorbidity, medications, and clinical metrics in the ICH, ischemic stroke, and myocardial infarction datasets

Age, year mean (SE)

71.1

(0.88)

68.7

(0.95)

0.062

71.3

(0.52)

71.2

(0.4)

0.78

65.4

(0.89)

66.4

(1.1)

0.5

Man, % (SE%)

58.5% (2.9%)

62.8% (2.8%)

0.32

53.4% (2%)

54.5% (1.4%)

0.71

80.6% (2.7%)

69.3% (3.6%)

0.02

Smokers, % (SE%)

5.8% (1.4%)

5.7%

(1.3%)

1

5.2% (0.9%)

7%

(0.7%)

0.18

9.6%

(2%)

11.8% (2.5%)

0.61

Diabetes Mellitus, % (SE%)

15.2% (2.1%)

12.7%

(2%)

0.45

17.7% (1.5%)

20.7% (1.2%)

0.15

20.7% (2.7%)

17.5% (3%)

0.5

Hypertension, % (SE%)

26.9% (2.6%)

26.9% (2.6%)

0.37

36% (1.9%)

34.5% (1.4%)

0.57

30.8% (3.1%)

26.8% (3.5%)

0.46

Chronic heart failure, % (SE%)

4.5% (1.2%)

4.5%

(1.2%)

0.76

5.9%

(1%)

4.8% (0.6%)

0.42

4.6% (1.4%)

5.6% (1.8%)

0.83

Anticoagulation and

anti-aggregation agents, % (SE%)

41.8% (3.0%)

28.8% (2.6%)

0.001

53.4% (2.0%)

35.2% (1.4%)

 < 0.001

52.1% (3.4%)

28.7% (3.6%)

 < 0.001

Hypertensive agents, % (SE%)

8.3% (1.6%)

6.1%

(1.4%)

0.36

5.4% (0.9%)

4.5% (0.6%)

0.47

4.1% (1.3%)

1.8% (1.0%)

0.34

White blood count median (IQR)

9.6

(7.5–12.6)

9.9

(7.8–12.9)

0.42

8.2

(6.7–9.9)

7.9

(6.5–9.8)

0.22

11.1

(8.9–13.8)

10.9

(9.1–13.6)

0.58

Hemoglobin count median (IQR)

12.9

(11.8–14.3)

13.3

(12.1–14.7)

0.007

13.4

(12.3–14.4)

13.4

(12.4–14.5)

0.37

14.2

(12.8–15.3)

14.2

(13–15.3)

0.76

Platelet count median (IQR)

216

(179–263)

230

(190–276)

0.009

226

(188–264)

228

(188–271)

0.28

233

(194–277)

254

(207–260)

0.01

CT-TAT

8.24

(7.41)

7.2

(6.49)

0.07

–-

–-

–-

–-

Emergency Severity Index 103, % (SE%)

54.4% (2.9%)

61.7% (2.8%)

0.13

81.4% (1.5%)

78.7% (1.2%)

0.12

44.7% (3.3%)

60.0% (3.8%)

0.57

Length of stay, days mean (SE)

19.5

(2.8)

18.0

(1.7)

0.193

6.9

(0.7)

8.6

(0.54)

0.002

6.2

(0.54)

5.4

(0.51)

0.221

Mortality after 30 days, % (SE%)

27.7% (2.9%)

17.5% (2.3%)

0.004

2.4% (0.06%)

3.6% (0.5%)

0.33

7.0% (1.8%)

11.0% (2.5%)

0.550

Mortality after 30 days, % change

 − 36.8%

50%

57.1%

Mortality after 120 days, % (SE%)

31.8% (2.9%)

21.7% (2.4%)

0.017

4.9% (0.9%)

6.0% (0.7%)

0.50

8.0% (1.9%)

14.5% (2.8%)

0.170

Mortality after 120 days, % change

 − 31.7%

22.4%

81.2%

Modified Ranking Scale baseline

0.76 (1.309)

0.77 (1.243)

0.944

–-

–-

–-

–-

Modified Ranking Scale Discharge

3.17 (2.193)

2.84 (1.911)

0.044

–-

–-

–-

–-

Modified Ranking Scale difference discharge, baseline

2.37 (2.219)

2.03 (1.951)

0.041

–-

–-

–-

–-